Dr. Collins speaks with NCATS Dr. Christopher Austin on new NIH clinical trial to test immune modulators for treatment of COVID-19
Dr. Collins and NCATS Director Dr. Christopher Austin host a Q&A on the latest clinical trial launched as part of NIH芒鈧劉s Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) partnership.
This page last reviewed on